awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50625165-C2263BEC-71B9-4A2A-A6CC-02CC3A91B74B
Q50625165-C2263BEC-71B9-4A2A-A6CC-02CC3A91B74B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50625165-C2263BEC-71B9-4A2A-A6CC-02CC3A91B74B
Cognitive Safety and Overall Tolerability of Imidafenacin in Clinical Use: A Long-Term, Open-Label, Post-Marketing Surveillance Study.
P2860
Q50625165-C2263BEC-71B9-4A2A-A6CC-02CC3A91B74B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50625165-C2263BEC-71B9-4A2A-A6CC-02CC3A91B74B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e81451d4626416d3fd93d7821ea492062648cb92
P2860
A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder.